

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.94427509 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.45879254 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.36291147 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.36291147 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.17030385 |
| 6 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.97239088 |
| 7 | negative regulation of cell killing (GO:0031342) | 4.78248793 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.78248793 |
| 9 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.57667178 |
| 10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.49449544 |
| 11 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.48260822 |
| 12 | positive regulation of granulocyte differentiation (GO:0030854) | 4.43769062 |
| 13 | positive regulation of B cell differentiation (GO:0045579) | 4.39875720 |
| 14 | response to interleukin-15 (GO:0070672) | 4.35771041 |
| 15 | definitive hemopoiesis (GO:0060216) | 4.16602849 |
| 16 | regulation of gamma-delta T cell activation (GO:0046643) | 4.16542869 |
| 17 | megakaryocyte development (GO:0035855) | 4.09335141 |
| 18 | regulation of B cell differentiation (GO:0045577) | 3.97833944 |
| 19 | negative thymic T cell selection (GO:0045060) | 3.95423206 |
| 20 | negative T cell selection (GO:0043383) | 3.93631203 |
| 21 | B cell receptor signaling pathway (GO:0050853) | 3.91761186 |
| 22 | detection of other organism (GO:0098543) | 3.90633263 |
| 23 | leukocyte aggregation (GO:0070486) | 3.90350960 |
| 24 | negative regulation of T cell mediated immunity (GO:0002710) | 3.87445737 |
| 25 | negative regulation of phagocytosis (GO:0050765) | 3.86029741 |
| 26 | positive thymic T cell selection (GO:0045059) | 3.80600425 |
| 27 | angiogenesis involved in wound healing (GO:0060055) | 3.78065306 |
| 28 | activated T cell proliferation (GO:0050798) | 3.76445939 |
| 29 | detection of bacterium (GO:0016045) | 3.73117450 |
| 30 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.66853391 |
| 31 | regulation of granulocyte differentiation (GO:0030852) | 3.54330565 |
| 32 | myeloid dendritic cell activation (GO:0001773) | 3.48580367 |
| 33 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.47539913 |
| 34 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.42205685 |
| 35 | microglial cell activation (GO:0001774) | 3.41078205 |
| 36 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.39523920 |
| 37 | cellular response to interleukin-15 (GO:0071350) | 3.39210901 |
| 38 | NIK/NF-kappaB signaling (GO:0038061) | 3.39073662 |
| 39 | pinocytosis (GO:0006907) | 3.38954475 |
| 40 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.37604067 |
| 41 | regulation of T cell tolerance induction (GO:0002664) | 3.36564752 |
| 42 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.35843015 |
| 43 | macrophage activation involved in immune response (GO:0002281) | 3.35775313 |
| 44 | positive regulation by symbiont of host defense response (GO:0052509) | 3.33878617 |
| 45 | modulation by symbiont of host defense response (GO:0052031) | 3.33878617 |
| 46 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.33878617 |
| 47 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.33878617 |
| 48 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.33878617 |
| 49 | modulation by symbiont of host immune response (GO:0052553) | 3.33878617 |
| 50 | T cell migration (GO:0072678) | 3.32900008 |
| 51 | interferon-gamma production (GO:0032609) | 3.31016205 |
| 52 | mature B cell differentiation (GO:0002335) | 3.30458636 |
| 53 | neutrophil activation involved in immune response (GO:0002283) | 3.30004805 |
| 54 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.29445842 |
| 55 | immunoglobulin mediated immune response (GO:0016064) | 3.28593158 |
| 56 | T cell homeostasis (GO:0043029) | 3.27939332 |
| 57 | detection of external biotic stimulus (GO:0098581) | 3.27466131 |
| 58 | mast cell activation (GO:0045576) | 3.25132919 |
| 59 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.24977817 |
| 60 | Peyers patch development (GO:0048541) | 3.19043952 |
| 61 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.19043952 |
| 62 | thymic T cell selection (GO:0045061) | 3.17538989 |
| 63 | response to muramyl dipeptide (GO:0032495) | 3.15384759 |
| 64 | response to host immune response (GO:0052572) | 3.13242567 |
| 65 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.13242567 |
| 66 | regulation of response to interferon-gamma (GO:0060330) | 3.12552749 |
| 67 | regulation of necroptotic process (GO:0060544) | 3.12277726 |
| 68 | regulation of mast cell degranulation (GO:0043304) | 3.11448235 |
| 69 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.10386272 |
| 70 | cellular response to zinc ion (GO:0071294) | 3.10364704 |
| 71 | T cell selection (GO:0045058) | 3.09091734 |
| 72 | neutrophil activation (GO:0042119) | 3.08923726 |
| 73 | lymphocyte homeostasis (GO:0002260) | 3.08865387 |
| 74 | positive T cell selection (GO:0043368) | 3.07454961 |
| 75 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.06609418 |
| 76 | T cell costimulation (GO:0031295) | 3.04640205 |
| 77 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.04449295 |
| 78 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.04003498 |
| 79 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.02896904 |
| 80 | detection of molecule of bacterial origin (GO:0032490) | 3.01399974 |
| 81 | lymphocyte costimulation (GO:0031294) | 3.00246325 |
| 82 | B cell homeostasis (GO:0001782) | 2.98787265 |
| 83 | regulation of tolerance induction (GO:0002643) | 2.98490531 |
| 84 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.98041839 |
| 85 | hepatocyte apoptotic process (GO:0097284) | 2.97952610 |
| 86 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.97415865 |
| 87 | dendritic cell chemotaxis (GO:0002407) | 2.97021415 |
| 88 | response to type I interferon (GO:0034340) | 2.96082813 |
| 89 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.96080735 |
| 90 | dendritic cell migration (GO:0036336) | 2.94963260 |
| 91 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.94571758 |
| 92 | positive regulation of interferon-alpha production (GO:0032727) | 2.94475113 |
| 93 | mature B cell differentiation involved in immune response (GO:0002313) | 2.94416027 |
| 94 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.94231833 |
| 95 | detection of biotic stimulus (GO:0009595) | 2.93537839 |
| 96 | negative regulation of interleukin-12 production (GO:0032695) | 2.93452102 |
| 97 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.93197308 |
| 98 | cellular response to type I interferon (GO:0071357) | 2.93008229 |
| 99 | type I interferon signaling pathway (GO:0060337) | 2.93008229 |
| 100 | tolerance induction (GO:0002507) | 2.92444239 |
| 101 | positive regulation of mast cell activation (GO:0033005) | 2.92045927 |
| 102 | negative regulation of granulocyte differentiation (GO:0030853) | 2.91184773 |
| 103 | myeloid cell activation involved in immune response (GO:0002275) | 2.90946112 |
| 104 | cellular extravasation (GO:0045123) | 2.90492616 |
| 105 | response to host (GO:0075136) | 2.90400205 |
| 106 | response to host defenses (GO:0052200) | 2.90400205 |
| 107 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.90400205 |
| 108 | myeloid dendritic cell differentiation (GO:0043011) | 2.90333957 |
| 109 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.89345729 |
| 110 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.87896998 |
| 111 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.87300826 |
| 112 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.86541991 |
| 113 | T cell receptor signaling pathway (GO:0050852) | 2.84736450 |
| 114 | regulation of interferon-alpha production (GO:0032647) | 2.84178900 |
| 115 | regulation of regulatory T cell differentiation (GO:0045589) | 2.83185623 |
| 116 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.83063164 |
| 117 | leukocyte degranulation (GO:0043299) | 2.82398849 |
| 118 | leukocyte homeostasis (GO:0001776) | 2.82203227 |
| 119 | T cell proliferation (GO:0042098) | 2.81571101 |
| 120 | negative regulation of necroptotic process (GO:0060546) | 2.81539581 |
| 121 | granulocyte activation (GO:0036230) | 2.81182843 |
| 122 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.81069786 |
| 123 | necroptotic process (GO:0070266) | 2.80971047 |
| 124 | negative regulation of B cell proliferation (GO:0030889) | 2.80406041 |
| 125 | positive regulation of isotype switching (GO:0045830) | 2.80325403 |
| 126 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.80099503 |
| 127 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.80099503 |
| 128 | response to protozoan (GO:0001562) | 2.79997030 |
| 129 | regulation of leukocyte degranulation (GO:0043300) | 2.79610985 |
| 130 | positive regulation of interleukin-2 production (GO:0032743) | 2.79233883 |
| 131 | macrophage activation (GO:0042116) | 2.78857338 |
| 132 | embryonic hemopoiesis (GO:0035162) | 2.77278758 |
| 133 | positive regulation of antigen processing and presentation (GO:0002579) | 2.75401413 |
| 134 | positive regulation of tolerance induction (GO:0002645) | 2.74474650 |
| 135 | response to peptidoglycan (GO:0032494) | 2.73969208 |
| 136 | regulation of mast cell activation (GO:0033003) | 2.73698222 |
| 137 | natural killer cell differentiation (GO:0001779) | 2.72760702 |
| 138 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.72055258 |
| 139 | lymph node development (GO:0048535) | 2.70539203 |
| 140 | defense response to protozoan (GO:0042832) | 2.68403454 |
| 141 | germinal center formation (GO:0002467) | 2.66624295 |
| 142 | natural killer cell activation (GO:0030101) | 2.65662788 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.96317709 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.86272121 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.85915215 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.33227015 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.98480344 |
| 6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.85208214 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.73491134 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.57017961 |
| 9 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.52308816 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.18918762 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.13159056 |
| 12 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.10770603 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.08562369 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.03012195 |
| 15 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.02921253 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.92965839 |
| 17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.90985819 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.90080270 |
| 19 | * MYB_26560356_Chip-Seq_TH2_Human | 2.72023244 |
| 20 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.67577137 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.67252522 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 2.52132420 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.46126767 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.44769497 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 2.41178317 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.40166968 |
| 27 | MYB_26560356_Chip-Seq_TH1_Human | 2.34895127 |
| 28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.32561334 |
| 29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.28966066 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.16113113 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.09379451 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.07736723 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.06928559 |
| 34 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.04874933 |
| 35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.04694410 |
| 36 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.01906667 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.96757676 |
| 38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.90109185 |
| 39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.88174019 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.80124922 |
| 41 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.79737259 |
| 42 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.72930272 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71605499 |
| 44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.69652874 |
| 45 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.63244268 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61408126 |
| 47 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.59612779 |
| 48 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59107441 |
| 49 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.57646101 |
| 50 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.55413324 |
| 51 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.53016737 |
| 52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.50996920 |
| 53 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50386750 |
| 54 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49019664 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.44242444 |
| 56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.43510041 |
| 57 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.42363380 |
| 58 | MAF_26560356_Chip-Seq_TH2_Human | 1.39494930 |
| 59 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.38873240 |
| 60 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.36484819 |
| 61 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.36084042 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.34857280 |
| 63 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.33992643 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32998423 |
| 65 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.32887928 |
| 66 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.28252131 |
| 67 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.25808860 |
| 68 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.24487536 |
| 69 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.23971463 |
| 70 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.23929744 |
| 71 | GATA3_26560356_Chip-Seq_TH2_Human | 1.21755164 |
| 72 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.18030625 |
| 73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17903342 |
| 74 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14632656 |
| 75 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.13869910 |
| 76 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10617957 |
| 77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10074100 |
| 78 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05578800 |
| 79 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.04090357 |
| 80 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04045950 |
| 81 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.02302930 |
| 82 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.02273416 |
| 83 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.96220291 |
| 84 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96166421 |
| 85 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93221461 |
| 86 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91551639 |
| 87 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90685988 |
| 88 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89770704 |
| 89 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89409747 |
| 90 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.88084052 |
| 91 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87737862 |
| 92 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85529076 |
| 93 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.84816006 |
| 94 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82074566 |
| 95 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.81702629 |
| 96 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.79635640 |
| 97 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76582564 |
| 98 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75548262 |
| 99 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.75508246 |
| 100 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.74827087 |
| 101 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.74473728 |
| 102 | GATA1_19941826_ChIP-Seq_K562_Human | 0.73895955 |
| 103 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.72001042 |
| 104 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71649126 |
| 105 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.71385542 |
| 106 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.70920558 |
| 107 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.70863767 |
| 108 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70815643 |
| 109 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69582723 |
| 110 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.63039617 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.47194896 |
| 2 | MP0000685_abnormal_immune_system | 3.39105174 |
| 3 | * MP0001800_abnormal_humoral_immune | 3.15714393 |
| 4 | MP0005671_abnormal_response_to | 3.13851895 |
| 5 | MP0002396_abnormal_hematopoietic_system | 3.02895208 |
| 6 | MP0001790_abnormal_immune_system | 2.92974445 |
| 7 | MP0005387_immune_system_phenotype | 2.92974445 |
| 8 | * MP0002452_abnormal_antigen_presenting | 2.83327895 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.67792850 |
| 10 | * MP0002723_abnormal_immune_serum | 2.63890784 |
| 11 | * MP0002420_abnormal_adaptive_immunity | 2.62486761 |
| 12 | * MP0001819_abnormal_immune_cell | 2.60910225 |
| 13 | MP0003763_abnormal_thymus_physiology | 2.56659120 |
| 14 | MP0002166_altered_tumor_susceptibility | 2.54301586 |
| 15 | MP0002419_abnormal_innate_immunity | 2.53733600 |
| 16 | MP0009785_altered_susceptibility_to | 2.53727989 |
| 17 | MP0005025_abnormal_response_to | 2.51579474 |
| 18 | * MP0002398_abnormal_bone_marrow | 2.46416233 |
| 19 | MP0003436_decreased_susceptibility_to | 2.44695619 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.39989647 |
| 21 | MP0003303_peritoneal_inflammation | 2.38809118 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.35746015 |
| 23 | * MP0000716_abnormal_immune_system | 2.22234422 |
| 24 | MP0004808_abnormal_hematopoietic_stem | 2.18896898 |
| 25 | MP0004510_myositis | 2.16095532 |
| 26 | MP0000689_abnormal_spleen_morphology | 2.01778844 |
| 27 | MP0002405_respiratory_system_inflammati | 2.01040544 |
| 28 | MP0006082_CNS_inflammation | 1.98586692 |
| 29 | MP0003724_increased_susceptibility_to | 1.97458576 |
| 30 | MP0002722_abnormal_immune_system | 1.97254911 |
| 31 | MP0002006_tumorigenesis | 1.95691592 |
| 32 | * MP0002429_abnormal_blood_cell | 1.88641486 |
| 33 | MP0001853_heart_inflammation | 1.87909314 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.86802286 |
| 35 | MP0000703_abnormal_thymus_morphology | 1.78503266 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.77982825 |
| 37 | MP0001873_stomach_inflammation | 1.74554821 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.65241000 |
| 39 | MP0001545_abnormal_hematopoietic_system | 1.64859956 |
| 40 | MP0005397_hematopoietic_system_phenotyp | 1.64859956 |
| 41 | MP0004947_skin_inflammation | 1.64464413 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.59398774 |
| 43 | MP0005174_abnormal_tail_pigmentation | 1.59008140 |
| 44 | MP0009333_abnormal_splenocyte_physiolog | 1.55959479 |
| 45 | MP0005310_abnormal_salivary_gland | 1.45216828 |
| 46 | MP0003183_abnormal_peptide_metabolism | 1.44612085 |
| 47 | MP0005058_abnormal_lysosome_morphology | 1.42851219 |
| 48 | MP0005451_abnormal_body_composition | 1.41019061 |
| 49 | MP0009278_abnormal_bone_marrow | 1.38460505 |
| 50 | MP0001851_eye_inflammation | 1.32924401 |
| 51 | MP0003690_abnormal_glial_cell | 1.30413831 |
| 52 | MP0003172_abnormal_lysosome_physiology | 1.30360781 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.28978055 |
| 54 | MP0003866_abnormal_defecation | 1.24432503 |
| 55 | MP0002933_joint_inflammation | 1.23880021 |
| 56 | MP0000858_altered_metastatic_potential | 1.23424787 |
| 57 | MP0008469_abnormal_protein_level | 1.19085759 |
| 58 | MP0000490_abnormal_crypts_of | 1.18346918 |
| 59 | MP0004381_abnormal_hair_follicle | 1.17811737 |
| 60 | MP0004883_abnormal_blood_vessel | 1.16125415 |
| 61 | MP0000569_abnormal_digit_pigmentation | 1.15902689 |
| 62 | MP0006054_spinal_hemorrhage | 1.13989723 |
| 63 | MP0008260_abnormal_autophagy | 1.13610648 |
| 64 | MP0000343_altered_response_to | 1.12427710 |
| 65 | MP0004036_abnormal_muscle_relaxation | 1.12198372 |
| 66 | MP0010352_gastrointestinal_tract_polyps | 1.11823267 |
| 67 | MP0003646_muscle_fatigue | 1.08499237 |
| 68 | MP0003448_altered_tumor_morphology | 1.04128665 |
| 69 | MP0005670_abnormal_white_adipose | 1.04107260 |
| 70 | MP0005075_abnormal_melanosome_morpholog | 1.02090497 |
| 71 | MP0003828_pulmonary_edema | 1.01157317 |
| 72 | MP0003566_abnormal_cell_adhesion | 0.99674434 |
| 73 | MP0004484_altered_response_of | 0.98548167 |
| 74 | MP0004084_abnormal_cardiac_muscle | 0.97336854 |
| 75 | MP0003045_fibrosis | 0.97209872 |
| 76 | MP0005166_decreased_susceptibility_to | 0.96183279 |
| 77 | MP0003075_altered_response_to | 0.95894605 |
| 78 | MP0000015_abnormal_ear_pigmentation | 0.93982464 |
| 79 | MP0001986_abnormal_taste_sensitivity | 0.92814243 |
| 80 | MP0010307_abnormal_tumor_latency | 0.92519780 |
| 81 | MP0002132_abnormal_respiratory_system | 0.89915388 |
| 82 | MP0002998_abnormal_bone_remodeling | 0.89296843 |
| 83 | MP0003191_abnormal_cellular_cholesterol | 0.86172057 |
| 84 | MP0002019_abnormal_tumor_incidence | 0.85857219 |
| 85 | MP0002009_preneoplasia | 0.85399448 |
| 86 | MP0003279_aneurysm | 0.84794974 |
| 87 | MP0009115_abnormal_fat_cell | 0.83226878 |
| 88 | MP0004130_abnormal_muscle_cell | 0.82331717 |
| 89 | MP0008057_abnormal_DNA_replication | 0.81938001 |
| 90 | MP0001879_abnormal_lymphatic_vessel | 0.79545464 |
| 91 | MP0000604_amyloidosis | 0.79488012 |
| 92 | MP0000371_diluted_coat_color | 0.79159562 |
| 93 | MP0009764_decreased_sensitivity_to | 0.79083231 |
| 94 | MP0002095_abnormal_skin_pigmentation | 0.78870988 |
| 95 | MP0005164_abnormal_response_to | 0.78749598 |
| 96 | MP0005076_abnormal_cell_differentiation | 0.78723405 |
| 97 | MP0002971_abnormal_brown_adipose | 0.76430486 |
| 98 | MP0002332_abnormal_exercise_endurance | 0.75395861 |
| 99 | MP0008007_abnormal_cellular_replicative | 0.75382694 |
| 100 | MP0003943_abnormal_hepatobiliary_system | 0.74720034 |
| 101 | MP0004185_abnormal_adipocyte_glucose | 0.74282468 |
| 102 | MP0000249_abnormal_blood_vessel | 0.73547358 |
| 103 | MP0000749_muscle_degeneration | 0.71544308 |
| 104 | MP0003656_abnormal_erythrocyte_physiolo | 0.71337106 |
| 105 | MP0004145_abnormal_muscle_electrophysio | 0.70460779 |
| 106 | MP0004087_abnormal_muscle_fiber | 0.69103876 |
| 107 | MP0005535_abnormal_body_temperature | 0.69030993 |
| 108 | MP0005390_skeleton_phenotype | 0.67908451 |
| 109 | MP0003221_abnormal_cardiomyocyte_apopto | 0.67076953 |
| 110 | MP0009765_abnormal_xenobiotic_induced | 0.66282339 |
| 111 | MP0000767_abnormal_smooth_muscle | 0.65860525 |
| 112 | MP0000759_abnormal_skeletal_muscle | 0.64772897 |
| 113 | MP0005375_adipose_tissue_phenotype | 0.64235406 |
| 114 | MP0008961_abnormal_basal_metabolism | 0.63287697 |
| 115 | MP0004264_abnormal_extraembryonic_tissu | 0.61829894 |
| 116 | MP0003795_abnormal_bone_structure | 0.58443606 |
| 117 | MP0001663_abnormal_digestive_system | 0.57922036 |
| 118 | MP0003077_abnormal_cell_cycle | 0.57424663 |
| 119 | MP0010094_abnormal_chromosome_stability | 0.57319440 |
| 120 | MP0010630_abnormal_cardiac_muscle | 0.56821342 |
| 121 | MP0002877_abnormal_melanocyte_morpholog | 0.55872178 |
| 122 | MP0009763_increased_sensitivity_to | 0.55792314 |
| 123 | MP0003091_abnormal_cell_migration | 0.53798756 |
| 124 | MP0003693_abnormal_embryo_hatching | 0.52282805 |
| 125 | MP0005666_abnormal_adipose_tissue | 0.51709162 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.87256061 |
| 2 | Myositis (HP:0100614) | 4.77806074 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.63676805 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.50202460 |
| 5 | Recurrent viral infections (HP:0004429) | 4.40770518 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.36596403 |
| 7 | Recurrent fungal infections (HP:0002841) | 4.18911533 |
| 8 | IgM deficiency (HP:0002850) | 4.11950064 |
| 9 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.94882551 |
| 10 | Stomatitis (HP:0010280) | 3.88931177 |
| 11 | Thrombocytosis (HP:0001894) | 3.87062662 |
| 12 | Agammaglobulinemia (HP:0004432) | 3.76743555 |
| 13 | Chronic otitis media (HP:0000389) | 3.70303381 |
| 14 | Panhypogammaglobulinemia (HP:0003139) | 3.58593425 |
| 15 | Cellulitis (HP:0100658) | 3.46976793 |
| 16 | Meningitis (HP:0001287) | 3.43474718 |
| 17 | Colitis (HP:0002583) | 3.38659707 |
| 18 | Recurrent skin infections (HP:0001581) | 3.37748792 |
| 19 | Recurrent bronchitis (HP:0002837) | 3.37577179 |
| 20 | Nasal polyposis (HP:0100582) | 3.35091290 |
| 21 | Orchitis (HP:0100796) | 3.33382720 |
| 22 | Recurrent cutaneous fungal infections (HP:0011370) | 3.30878877 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.30878877 |
| 24 | Inflammation of the large intestine (HP:0002037) | 3.27915535 |
| 25 | Spontaneous hematomas (HP:0007420) | 3.27571841 |
| 26 | B lymphocytopenia (HP:0010976) | 3.25622903 |
| 27 | Abnormality of B cell number (HP:0010975) | 3.25622903 |
| 28 | Retrobulbar optic neuritis (HP:0100654) | 3.22926634 |
| 29 | Optic neuritis (HP:0100653) | 3.22926634 |
| 30 | Thyroiditis (HP:0100646) | 3.20406865 |
| 31 | Abnormality of T cells (HP:0002843) | 3.13137086 |
| 32 | Abnormality of the nasal mucosa (HP:0000433) | 3.11977734 |
| 33 | Gastrointestinal inflammation (HP:0004386) | 3.11014575 |
| 34 | Mediastinal lymphadenopathy (HP:0100721) | 3.08751062 |
| 35 | T lymphocytopenia (HP:0005403) | 3.06979712 |
| 36 | Abnormality of T cell number (HP:0011839) | 3.03945742 |
| 37 | Vasculitis (HP:0002633) | 3.03540502 |
| 38 | Arterial thrombosis (HP:0004420) | 3.01568378 |
| 39 | Abnormality of T cell physiology (HP:0011840) | 3.01465979 |
| 40 | Nemaline bodies (HP:0003798) | 2.98662787 |
| 41 | Exercise-induced myalgia (HP:0003738) | 2.90649485 |
| 42 | Muscle fiber inclusion bodies (HP:0100299) | 2.90487738 |
| 43 | Abnormality of the fingertips (HP:0001211) | 2.88536703 |
| 44 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.88303564 |
| 45 | Chronic obstructive pulmonary disease (HP:0006510) | 2.87866600 |
| 46 | Obstructive lung disease (HP:0006536) | 2.87866600 |
| 47 | Increased cerebral lipofuscin (HP:0011813) | 2.87442299 |
| 48 | Gastrointestinal stroma tumor (HP:0100723) | 2.86433692 |
| 49 | Papilledema (HP:0001085) | 2.84927578 |
| 50 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.83465875 |
| 51 | Autoimmune hemolytic anemia (HP:0001890) | 2.83461380 |
| 52 | Eosinophilia (HP:0001880) | 2.80639667 |
| 53 | Abnormality of macrophages (HP:0004311) | 2.76631776 |
| 54 | Leukocytosis (HP:0001974) | 2.69284676 |
| 55 | Prolonged bleeding time (HP:0003010) | 2.69226785 |
| 56 | Hematochezia (HP:0002573) | 2.66723431 |
| 57 | Chest pain (HP:0100749) | 2.65866279 |
| 58 | Chronic diarrhea (HP:0002028) | 2.63929877 |
| 59 | Lymphopenia (HP:0001888) | 2.61673666 |
| 60 | Osteomyelitis (HP:0002754) | 2.60207240 |
| 61 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.59790705 |
| 62 | Abnormality of eosinophils (HP:0001879) | 2.56678471 |
| 63 | Disinhibition (HP:0000734) | 2.52099748 |
| 64 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.52092369 |
| 65 | Granulocytopenia (HP:0001913) | 2.51575047 |
| 66 | Keratoconjunctivitis sicca (HP:0001097) | 2.50678413 |
| 67 | Papilloma (HP:0012740) | 2.50080145 |
| 68 | Verrucae (HP:0200043) | 2.50080145 |
| 69 | Autoimmune thrombocytopenia (HP:0001973) | 2.49411609 |
| 70 | Recurrent sinusitis (HP:0011108) | 2.47109075 |
| 71 | Pulmonary infiltrates (HP:0002113) | 2.46676623 |
| 72 | IgG deficiency (HP:0004315) | 2.45723278 |
| 73 | Epistaxis (HP:0000421) | 2.44359415 |
| 74 | Pulmonary embolism (HP:0002204) | 2.44116127 |
| 75 | Periodontitis (HP:0000704) | 2.43607725 |
| 76 | Encephalitis (HP:0002383) | 2.41186786 |
| 77 | Muscle fiber splitting (HP:0003555) | 2.39302280 |
| 78 | Easy fatigability (HP:0003388) | 2.36319707 |
| 79 | Petechiae (HP:0000967) | 2.35952935 |
| 80 | Urticaria (HP:0001025) | 2.35421048 |
| 81 | Pustule (HP:0200039) | 2.35123608 |
| 82 | Acute myeloid leukemia (HP:0004808) | 2.31955974 |
| 83 | IgA deficiency (HP:0002720) | 2.30750583 |
| 84 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.29765220 |
| 85 | Interstitial pulmonary disease (HP:0006530) | 2.29356135 |
| 86 | Increased IgE level (HP:0003212) | 2.28786054 |
| 87 | Subaortic stenosis (HP:0001682) | 2.26240782 |
| 88 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.26240782 |
| 89 | Acute hepatic failure (HP:0006554) | 2.25011842 |
| 90 | Increased IgM level (HP:0003496) | 2.24216247 |
| 91 | Keratoconjunctivitis (HP:0001096) | 2.23572953 |
| 92 | Hypoplasia of the thymus (HP:0000778) | 2.19587862 |
| 93 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.18312801 |
| 94 | Hemoptysis (HP:0002105) | 2.17873545 |
| 95 | Difficulty running (HP:0009046) | 2.17269906 |
| 96 | Viral hepatitis (HP:0006562) | 2.17039307 |
| 97 | Hemiplegia (HP:0002301) | 2.15090787 |
| 98 | Amaurosis fugax (HP:0100576) | 2.14988147 |
| 99 | Gingival bleeding (HP:0000225) | 2.14357690 |
| 100 | Abnormal platelet function (HP:0011869) | 2.13999726 |
| 101 | Impaired platelet aggregation (HP:0003540) | 2.13999726 |
| 102 | Abnormality of the prostate (HP:0008775) | 2.13187836 |
| 103 | Toxemia of pregnancy (HP:0100603) | 2.12958000 |
| 104 | Gingivitis (HP:0000230) | 2.12477364 |
| 105 | Severe combined immunodeficiency (HP:0004430) | 2.09966939 |
| 106 | Volvulus (HP:0002580) | 2.09016175 |
| 107 | Vertigo (HP:0002321) | 2.08699232 |
| 108 | Recurrent pneumonia (HP:0006532) | 2.05805198 |
| 109 | Recurrent lower respiratory tract infections (HP:0002783) | 2.05025175 |
| 110 | Asymmetric septal hypertrophy (HP:0001670) | 2.04889739 |
| 111 | Hyporeflexia of lower limbs (HP:0002600) | 2.03518721 |
| 112 | Increased variability in muscle fiber diameter (HP:0003557) | 2.00711723 |
| 113 | Facial diplegia (HP:0001349) | 1.98288191 |
| 114 | Spondylolisthesis (HP:0003302) | 1.98257608 |
| 115 | Chronic sinusitis (HP:0011109) | 1.97345719 |
| 116 | Abnormality of the pleura (HP:0002103) | 1.97295115 |
| 117 | Vacuolated lymphocytes (HP:0001922) | 1.96645346 |
| 118 | Fatigue (HP:0012378) | 1.95460123 |
| 119 | Hypergammaglobulinemia (HP:0010702) | 1.93159947 |
| 120 | Sepsis (HP:0100806) | 1.92883616 |
| 121 | EMG: myopathic abnormalities (HP:0003458) | 1.91625436 |
| 122 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.91238199 |
| 123 | Gastrointestinal infarctions (HP:0005244) | 1.90854347 |
| 124 | Amyloidosis (HP:0011034) | 1.90764767 |
| 125 | Lymphoma (HP:0002665) | 1.90050282 |
| 126 | Basal ganglia calcification (HP:0002135) | 1.88427089 |
| 127 | Combined immunodeficiency (HP:0005387) | 1.87004451 |
| 128 | Absent frontal sinuses (HP:0002688) | 1.85234823 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.40433057 |
| 2 | BMPR2 | 3.08588706 |
| 3 | TXK | 2.88171584 |
| 4 | BLK | 2.86676403 |
| 5 | PRPF4B | 2.73596698 |
| 6 | JAK3 | 2.67795117 |
| 7 | KIT | 2.52223374 |
| 8 | IRAK4 | 2.50361614 |
| 9 | TYK2 | 2.43316181 |
| 10 | MAP3K14 | 2.21120912 |
| 11 | ZAP70 | 2.16884585 |
| 12 | STK10 | 2.11978132 |
| 13 | ITK | 2.08146753 |
| 14 | IKBKB | 2.07450041 |
| 15 | BTK | 2.04339877 |
| 16 | TBK1 | 2.02708297 |
| 17 | TGFBR2 | 1.98247046 |
| 18 | TEC | 1.95372736 |
| 19 | TNK2 | 1.95327380 |
| 20 | DMPK | 1.92864946 |
| 21 | PIK3CG | 1.88951324 |
| 22 | CSF1R | 1.87119140 |
| 23 | IKBKE | 1.87048778 |
| 24 | SYK | 1.82154892 |
| 25 | EEF2K | 1.72369743 |
| 26 | OBSCN | 1.69845323 |
| 27 | FES | 1.69151668 |
| 28 | RIPK4 | 1.68117822 |
| 29 | JAK1 | 1.64814184 |
| 30 | MAP3K13 | 1.63770026 |
| 31 | FLT3 | 1.61868792 |
| 32 | FGFR3 | 1.56056566 |
| 33 | MAP2K3 | 1.50277112 |
| 34 | EPHB1 | 1.41215005 |
| 35 | TAOK3 | 1.35186454 |
| 36 | HCK | 1.34474213 |
| 37 | LCK | 1.32798674 |
| 38 | GRK6 | 1.28875358 |
| 39 | LRRK2 | 1.23395230 |
| 40 | CSK | 1.21262978 |
| 41 | TRPM7 | 1.13594427 |
| 42 | CHUK | 1.12244616 |
| 43 | TRIB3 | 1.08822125 |
| 44 | PKN2 | 1.06173577 |
| 45 | FGFR4 | 1.04740114 |
| 46 | LYN | 1.01765069 |
| 47 | ERN1 | 0.99844089 |
| 48 | CLK1 | 0.99440521 |
| 49 | MAPK7 | 0.99202448 |
| 50 | TTN | 0.94955521 |
| 51 | STK4 | 0.94287566 |
| 52 | NUAK1 | 0.92099735 |
| 53 | PIM1 | 0.88737040 |
| 54 | NLK | 0.87001807 |
| 55 | MAP3K1 | 0.86892455 |
| 56 | NEK9 | 0.85468019 |
| 57 | CAMK1D | 0.80971802 |
| 58 | STK24 | 0.80599590 |
| 59 | PTK6 | 0.78988821 |
| 60 | MATK | 0.78821514 |
| 61 | IRAK3 | 0.77916145 |
| 62 | KSR2 | 0.76901050 |
| 63 | RPS6KA4 | 0.76871347 |
| 64 | YES1 | 0.76273460 |
| 65 | CDK9 | 0.75509848 |
| 66 | NME2 | 0.75110060 |
| 67 | CAMK1G | 0.74441338 |
| 68 | EPHA3 | 0.74298217 |
| 69 | PRKCQ | 0.73511423 |
| 70 | FGR | 0.72089882 |
| 71 | MARK2 | 0.71359691 |
| 72 | IRAK1 | 0.68105653 |
| 73 | MAP3K3 | 0.66636705 |
| 74 | GRK7 | 0.66133435 |
| 75 | HIPK2 | 0.64735536 |
| 76 | JAK2 | 0.64696649 |
| 77 | PIK3CA | 0.62214581 |
| 78 | TGFBR1 | 0.59679715 |
| 79 | SIK2 | 0.59541297 |
| 80 | RET | 0.56320397 |
| 81 | RPS6KB2 | 0.54972206 |
| 82 | CAMKK1 | 0.54328100 |
| 83 | PDK1 | 0.54189175 |
| 84 | FYN | 0.53783860 |
| 85 | MARK3 | 0.53249151 |
| 86 | MST4 | 0.52676136 |
| 87 | PAK4 | 0.52641072 |
| 88 | MAP3K10 | 0.49211978 |
| 89 | SGK2 | 0.48896749 |
| 90 | CDK4 | 0.47690324 |
| 91 | MAP3K5 | 0.47465974 |
| 92 | RPS6KC1 | 0.46922799 |
| 93 | RPS6KL1 | 0.46922799 |
| 94 | MAPKAPK2 | 0.46914829 |
| 95 | CDK6 | 0.46496725 |
| 96 | BRSK2 | 0.45169784 |
| 97 | ALK | 0.44989890 |
| 98 | PDGFRB | 0.44953021 |
| 99 | PDPK1 | 0.44493008 |
| 100 | SGK3 | 0.43989699 |
| 101 | CAMKK2 | 0.43599744 |
| 102 | ADRBK2 | 0.41766197 |
| 103 | MAP3K6 | 0.41118571 |
| 104 | GSK3A | 0.40650415 |
| 105 | MOS | 0.40256436 |
| 106 | RAF1 | 0.39284904 |
| 107 | RPS6KA6 | 0.39267850 |
| 108 | TAOK1 | 0.38354353 |
| 109 | MAP3K7 | 0.37692191 |
| 110 | MAPK3 | 0.37493805 |
| 111 | PRKAA2 | 0.36008067 |
| 112 | PRKD2 | 0.35822395 |
| 113 | CDC42BPA | 0.35615060 |
| 114 | ABL1 | 0.35296525 |
| 115 | MAPK11 | 0.34490295 |
| 116 | MAPKAPK3 | 0.34374348 |
| 117 | ATR | 0.33064266 |
| 118 | MAP3K11 | 0.33027363 |
| 119 | CDK19 | 0.32906816 |
| 120 | TIE1 | 0.32839138 |
| 121 | FRK | 0.30485456 |
| 122 | MAPK12 | 0.30346437 |
| 123 | STK11 | 0.30137302 |
| 124 | TAOK2 | 0.29688412 |
| 125 | BRD4 | 0.29670375 |
| 126 | MAP3K8 | 0.29632342 |
| 127 | CDK12 | 0.29481621 |
| 128 | MAPK4 | 0.29340119 |
| 129 | SIK3 | 0.29318346 |
| 130 | PRKCH | 0.29090356 |
| 131 | WNK1 | 0.28900877 |
| 132 | IRAK2 | 0.28818223 |
| 133 | DYRK1B | 0.28705357 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.45667131 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.82568134 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.65042254 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.52074039 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.47371389 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.47040350 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.43901796 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.36032003 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.34014815 |
| 10 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.20175838 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.14656196 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.10406127 |
| 13 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.89604822 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.83624006 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.81231997 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.73762189 |
| 17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.68531670 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.65111820 |
| 19 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.64284396 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.62673096 |
| 21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.61859766 |
| 22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.53821372 |
| 23 | Apoptosis_Homo sapiens_hsa04210 | 1.49867735 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.47870372 |
| 25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.47834052 |
| 26 | Platelet activation_Homo sapiens_hsa04611 | 1.46843745 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.46777933 |
| 28 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.45176909 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.40495663 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.40402770 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.39931421 |
| 32 | Tuberculosis_Homo sapiens_hsa05152 | 1.39258636 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.37569858 |
| 34 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.37383622 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.32032233 |
| 36 | Pertussis_Homo sapiens_hsa05133 | 1.25199481 |
| 37 | Legionellosis_Homo sapiens_hsa05134 | 1.23148797 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.22513529 |
| 39 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.17780590 |
| 40 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.17073725 |
| 41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.16259152 |
| 42 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.13887449 |
| 43 | Other glycan degradation_Homo sapiens_hsa00511 | 1.12102757 |
| 44 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.06148476 |
| 45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.05711481 |
| 46 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.02743145 |
| 47 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.02195651 |
| 48 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.01817602 |
| 49 | Malaria_Homo sapiens_hsa05144 | 1.01614854 |
| 50 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.94765414 |
| 51 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.94494901 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.92940259 |
| 53 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.92644675 |
| 54 | * Pancreatic cancer_Homo sapiens_hsa05212 | 0.89500714 |
| 55 | Asthma_Homo sapiens_hsa05310 | 0.89367283 |
| 56 | DNA replication_Homo sapiens_hsa03030 | 0.85655934 |
| 57 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.84584876 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.84393177 |
| 59 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.83231388 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 0.82600977 |
| 61 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79538220 |
| 62 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.79427345 |
| 63 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.79394365 |
| 64 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.77595331 |
| 65 | Lysosome_Homo sapiens_hsa04142 | 0.75909225 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75884736 |
| 67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75502730 |
| 68 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.74285197 |
| 69 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.73754503 |
| 70 | Base excision repair_Homo sapiens_hsa03410 | 0.73697449 |
| 71 | HTLV-I infection_Homo sapiens_hsa05166 | 0.73674156 |
| 72 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.73585894 |
| 73 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.72359341 |
| 74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69206357 |
| 75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67873825 |
| 76 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.64517238 |
| 77 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.62233797 |
| 78 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.61064832 |
| 79 | Long-term potentiation_Homo sapiens_hsa04720 | 0.59980610 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.57238404 |
| 81 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57109629 |
| 82 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.56969336 |
| 83 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.56681218 |
| 84 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.56259399 |
| 85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56160191 |
| 86 | Glioma_Homo sapiens_hsa05214 | 0.55514963 |
| 87 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55454855 |
| 88 | Renin secretion_Homo sapiens_hsa04924 | 0.54845671 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54558279 |
| 90 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.53555874 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52362862 |
| 92 | Colorectal cancer_Homo sapiens_hsa05210 | 0.52331515 |
| 93 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.51610045 |
| 94 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51304468 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48593121 |
| 96 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.47989519 |
| 97 | Mismatch repair_Homo sapiens_hsa03430 | 0.47915992 |
| 98 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47758659 |
| 99 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.47700675 |
| 100 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45718891 |
| 101 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44909725 |
| 102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44023956 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43116918 |
| 104 | Phagosome_Homo sapiens_hsa04145 | 0.42573084 |
| 105 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.42259226 |
| 106 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.41050149 |
| 107 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.40757283 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40221679 |
| 109 | Focal adhesion_Homo sapiens_hsa04510 | 0.40007291 |
| 110 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.39208466 |
| 111 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38232980 |
| 112 | Prostate cancer_Homo sapiens_hsa05215 | 0.37393326 |
| 113 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.36339846 |
| 114 | Endocytosis_Homo sapiens_hsa04144 | 0.35900857 |
| 115 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.35899309 |
| 116 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.35027964 |
| 117 | Amoebiasis_Homo sapiens_hsa05146 | 0.32705358 |
| 118 | Pathways in cancer_Homo sapiens_hsa05200 | 0.32153887 |
| 119 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31329834 |
| 120 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.31025841 |
| 121 | Cell cycle_Homo sapiens_hsa04110 | 0.30109505 |
| 122 | Ribosome_Homo sapiens_hsa03010 | 0.29163700 |
| 123 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.28604818 |

